Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
BKM120 in Cancers With PIK3CA Activating Mutations
This study has been terminated.
( The study has been closed due to lack of accrual )
Study NCT01501604 Information provided by Massachusetts General Hospital
First Received on December 27, 2011. Last Updated on January 24, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Lung Cancer
Breast Cancer
Colorectal Cancer
Cholangiocarcinoma
Solid Tumors
Additional conditions recognized in this trial
Breast Neoplasms
Colorectal Neoplasms
Lung Neoplasms
More general conditions related to this trial
Adenocarcinoma
Breast Diseases
Carcinoma
Colonic Diseases
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Intestinal Neoplasms
Lung Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Rectal Diseases
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Skin Diseases
Thoracic Neoplasms
Interventions listed in this trial
BKM120
Sponsors listed in this trial
Massachusetts General Hospital
Novartis Pharmaceuticals
Back to top of Main Content